Application 206803
- Type
- ANDA
- Sponsor
- RISING
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SELEGILINE HYDROCHLORIDE | SELEGILINE HYDROCHLORIDE | CAPSULE;ORAL | 5MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 16571-659 | Selegiline Hydrochloride | Selegiline Hydrochloride | Rising Pharmaceuticals, Inc. | ANDA | Current |
| 16571-659 | Selegiline Hydrochloride | Selegiline Hydrochloride | Rising Pharma Holdings, Inc. | ANDA | Current |
| 71205-888 | Selegiline Hydrochloride | Selegiline Hydrochloride | Proficient Rx LP | ANDA | Current |
| 71205-888 | Selegiline Hydrochloride | Selegiline Hydrochloride | Proficient Rx LP | ANDA | Current |